Publication of Annual Report and Accounts

RNS Number : 7318L

Redx Pharma plc

28 December 2018

 

28 December 2018

REDX PHARMA PLC

("Redx" or "the Company")

Annual Report and Accounts

The Company announces that it will today be posting to shareholders the Annual Report and Accounts for the year ended 30 September 2018, together with the notice of the Annual General Meeting.  The Annual General Meeting will be held at 11am on 23 January 2019 at the offices of WG Partners, 85 Gresham Street, London EC2V 7NQ.

The Report and Accounts are also available on the Company's website, www.redxpharma.com.

For further information, please contact:

Redx Pharma Plc	T: [phone]
Lisa Anson, Chief Executive Officer
Dominic Jackson, Chief Financial Officer
Cantor Fitzgerald Europe (Nominated Advisor & Joint Broker)	T: [phone]
Phil Davies
WG Partners LLP (Joint Broker)	T: [phone]
Claes Spång/ Chris Lee/ David Wilson
FTI Consulting	T: [phone]
Simon Conway/Stephanie Cuthbert

About Redx Pharma Plc 

Redx is a UK based biotechnology company whose shares are traded on AIM (AIM:REDX). Redx's vision is to become a leading biotech focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases.

If you would like to sign up to regular alerts from Redx Pharma, please follow this link https://www.redxpharma.com/investors/email-alerts/

 

END

 

 

ACSDMMZZMRDGRZM